{"id":53734,"date":"2025-02-04T09:00:00","date_gmt":"2025-02-04T08:00:00","guid":{"rendered":"https:\/\/www.stille.se\/us\/mfn_news\/the-nomination-committees-proposal-for-a-new-board-at-stille-ab\/"},"modified":"2026-08-10T13:02:32","modified_gmt":"2026-08-10T11:02:32","slug":"the-nomination-committees-proposal-for-a-new-board-at-stille-ab","status":"publish","type":"mfn_news","link":"https:\/\/www.stille.se\/us\/news\/the-nomination-committees-proposal-for-a-new-board-at-stille-ab\/","title":{"rendered":"The Nomination Committee\u2019s Proposal for a New Board at Stille AB"},"content":{"rendered":"
\n

Stille AB (publ) announces the Nomination Committee’s proposal for a new board composition for the 2025 Annual General Meeting. Chairman of the Board Lars Kvarnhem has declined re-election, and Jón Sigurdsson is proposed as the new Chairman of the Board.<\/strong><\/p>\n<\/div>\n

\n

The Nomination Committee proposes the re-election of Per Carlsson, Yonna Olsson, Victor Steien, and Jens Viebke, and that Jón Sigurdsson be elected as Chairman of the Board. Lars Kvarnhem has informed the Nomination Committee that he declines re-election.<\/p>\n

Jón Sigurdsson is, among other, Chairman of the Board at Vitrolife (publ) and has previously been the CEO of Össur. Jón has extensive experience in both organic and acquisition-driven growth.<\/p>\n

The Nomination Committee’s remaining proposals will be presented in the notice for the Annual General Meeting.<\/p>\n

The current Nomination Committee at Stille consists of Bengt Julander, appointed by Linc AB, Chairman of the Nomination Committee, Fredrik Strömholm, appointed by Impilo, Leif Almhorn, appointed by SEB Asset Management, and Lars Kvarnhem, Chairman of the Board.<\/p>\n

Torshälla, February 4th, 2025.<\/p>\n<\/div>\n

\n

Contact Details<\/strong>
Lars Kvarnhem<\/strong>
Chairman of the Board
+46 (0)70 512 00 21 | lars.kvarnhem@priego.se<\/a><\/p>\n<\/div>\n

\n

About Us<\/strong>
Stille AB (publ) develops, manufactures and markets medical devices<\/strong> for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se<\/a>.<\/p>\n<\/div>\n

\n

Attachments<\/strong>
The Nomination Committee’s Proposal for a New Board at Stille AB<\/a><\/p>\n<\/div>\n